Clinical Trial Update: Safety Study of Dantrolene to Treat Cerebral Vasospasm After Subarachnoid Hemorrhage [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 safety study of dantrolene for treating cerebral vasospasm after subarachnoid hemorrhage has completed with results posted in 2012.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cerebral Vasospasm
• Subarachnoid Hemorrhage

Drugs mentioned

• Dantrolene (dantrolene)

Snippet

Sponsor: University of Massachusetts, Worcester | Conditions: Cerebral Vasospasm After Subarachnoid Hemorrhage | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2012-05-25